Europe’s opportunity to open up drug regulation
di redazione
Published on BMJ 2010; 340: C1578
Among the priorities for the European health directorate, DG Sanco, as it takes control of the agency in charge of drug regulation should be to end the secrecy surrounding approval decisions, say Silvio Garattini and Vittorio Bertelé